• Molecules directed against tumor cells patented

    Researchers at the ImmunoSensation cluster of excellence at the University of Bonn have managed to do what many scientists dream of: together with researchers from the USA, they have patented new molecules that allow the immune system to be directed against tumor cells.

    Press Release

  • How an Ebola vaccine candidate activates our immune system

    In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. In a further trial, DZIF scientists have now shown in detail how our immune systems react to the tested vaccine "rVSV-ZEBOV" for the first time.

    Press Release

  • "Good to see both sides"

    Oumou Maiga-Ascofaré is currently working as a research fellow at the Bernhard Nocht Institute for Tropical Medicine in Hamburg and at the Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) in Kumasi, Ghana. We asked her about her work in DZIF and her life among different cultures.


  • A list of pathogens sets priorities for antibiotic research

    The WHO has published a list of 12 bacteria groups which are to be given priority for future new antibiotic research and development. DZIF scientists at the University of Tübingen were substantially involved in developing this priority list.

    Press Release

  • New malaria vaccine effective in clinical trial

    Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

    Press Release


  • 20 June 2017 - PRESS RELEASE

    Maximilian Muenchhoff has been honoured with the HIV/AIDS Research Award

    Some HIV-infected – and untreated children – who do not develop AIDS, control the virus in a different way from the few infected adults who remain disease-free. Dr Maximilian Muenchhoff, DZIF scientist at LMU´s Max von Pettenkofer Institute, has been honoured for characterizing the immunological mechanisms with the HIV/AIDS Research Award of the German Society of Infectious Diseases.more ]